GGrantIndex
Sort

46,585 grants matching heart failure

IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury

$411,747
Yigang Wang · University Of Cincinnati · R01 · FY2021 · HL

3D MRI-Based Modeling for Computer-Aided Right Ventricle Remodeling Surgery

$411,700
Pedro J. Del Nido · Boston Children'S Hospital · R01 · FY2011 · HL

Novel Role for Circulating extracellular RNAs in Human Heart Failure

$411,672
Saumya Das · Massachusetts General Hospital · R01 · FY2017 · HL

Novel Role for Circulating extracellular RNAs in Human Heart Failure

$411,672
Saumya Das · Massachusetts General Hospital · R01 · FY2018 · HL

Cadherin regulation of planar polarity

$411,663
Sara N Stahley · Pennsylvania State Univ Hershey Med Ctr · R35 · FY2024 · GM

Ethanol Effects on Recovery after Injury

$411,594
Elizabeth J Kovacs · Loyola University Chicago · R01 · FY2011 · AA

Regulation of cardiac gene expression by MEF2-Myocardin transcription complexes

$411,565
Brian L Black · J. David Gladstone Institutes · P01 · FY2013 · HL

NO signaling by a Soluble Guanylyl Cyclase-Thioredoxin transnitrosation complex

$411,557
Annie V Beuve · Rbhs-New Jersey Medical School · R01 · FY2016 · GM

NO signaling by a Soluble Guanylyl Cyclase-Thioredoxin transnitrosation complex

$411,557
Annie V Beuve · Rbhs-New Jersey Medical School · R01 · FY2015 · GM

NO signaling by a Soluble Guanylyl Cyclase-Thioredoxin transnitrosation complex

$411,557
Annie V Beuve · Rbhs-New Jersey Medical School · R01 · FY2017 · GM

NO signaling by a Soluble Guanylyl Cyclase-Thioredoxin transnitrosation complex

$411,557
Annie V Beuve · Rbhs-New Jersey Medical School · R01 · FY2018 · GM

Mechanisms of cardiomyocyte-extracellular matrix interactions in cardiogenesis

$411,542
Jennifer Schumacher · Miami University Oxford · R15 · FY2021 · HD

ARNT: A novel regulator of cardiac vascular endothelial barrier function in heart failure

$411,515
Rongxue Wu · University Of Chicago · R01 · FY2021 · HL

ARNT: A novel regulator of cardiac vascular endothelial barrier function in heart failure

$411,515
Rongxue Wu · University Of Chicago · R01 · FY2023 · HL

ARNT: A novel regulator of cardiac vascular endothelial barrier function in heart failure

$411,515
Rongxue Wu · University Of Chicago · R01 · FY2020 · HL

ARNT: A novel regulator of cardiac vascular endothelial barrier function in heart failure

$411,515
Rongxue Wu · University Of Chicago · R01 · FY2019 · HL

ARNT: A novel regulator of cardiac vascular endothelial barrier function in heart failure

$411,515
Rongxue Wu · University Of Chicago · R01 · FY2022 · HL

Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients

$411,500
Bernhard Kuhn · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL

Dynamic Single Cell Imaging of Coronary Microvascular Dysfunction in the Failing Heart

$411,499
Aaron D Aguirre · Massachusetts General Hospital · R01 · FY2021 · HL

Risk prediction of breast cancer treatment-related cardiotoxicity to guide clinical decision making

$411,468
Reina Haque · Kaiser Foundation Research Institute · R01 · FY2020 · HL

PICOT and Cardiac Hypertrophy

$411,461
Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · HL

PICOT and Cardiac Hypertrophy

$411,461
Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · HL

PICOT and Cardiac Hypertrophy

$411,461
Roger Joseph Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · HL

PICOT and Cardiac Hypertrophy

$411,461
Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · HL

Molecular mechanism of senile cardiac amyloidosis

$411,459
Lawreen H. Connors · Boston University Medical Campus · R56 · FY2017 · AG